فهرست مطالب zeinab nourieh

Brown rice (BR) is unpolished rice with various beneficial compounds such as vitamins, magnesium and other minerals, dietary fiber, essential fatty acids, γ‑oryzanol and γ‑aminobutyric acid. In the present study, we compared the effects of white rice (WR) and BR on inflammatory marker high‑sensitivity C‑reactive protein (hs‑CRP) and cardiovascular risk factors among non‑menopausal overweight or obese female. In a randomized cross‑over clinical trial, 40 overweight or obese (body mass index (BMI) >25) women were randomly allocated to group 1 (n = 20): Treatment with BR diet and group 2 (n = 20): Treatment with WR diet for 6 weeks (first intervention period). Two participants in group 2 dropped out during this period. After a 2‑week washout period, individuals were switched to the alternate diet for an additional 6 weeks (second intervention period) and three subjects in group 2 did not follow this period and eliminated, finally this study was completed with 35 subjects (group 1 = 20 and group 2 = 15). Each one was instructed to consume 150 g cooked WR or BR daily in each intervention period. Cardiovascular risk factors including BMI, waist and hip circumference, blood pressure, serum lipid profiles, fasting blood glucose (FBG) and hs‑CRP as an inflammatory marker, were measured 4 times (in study week 0, 6, 8, 14). BR diet in comparison with WR diet could significantly reduce weight, waist and hip circumference, BMI, Diastole blood pressure and hs‑CRP. No significant differences between the two diets were found regarding lipid profiles and FBG. The present results suggest that BR replacement in the diet may be useful to decrease inflammatory marker level and several cardiovascular risk factors among non‑menopausal overweight or obese female.

Soy milk replacement in the diet might have beneficial effects on waist circumference and cardiovascular risk factors for overweight and obese subjects. Therefore, we are going to determine the effects of soy milk replacements on the waist circumference and cardiovascular risk factors among overweight and obese female adults. In this crossover randomized clinical trail, 24 over weight and obese female adults were on a diet with soy milk or the diet with cow’s milk for four weeks. In the diet with soy milk only one glass of soy milk (240 cc) was replaced instead of one glass of cow’s milk (240 cc). Measurements were done according to the standard protocol. Waist circumference reduced significantly following soy milk period (mean percent change in soy milk period for waist circumference: ‑3.79 ± 0.51 vs. ‑1.78 ± 0.55 %; P = 0.02 in the cow’s milk period). Blood pressure, weight, liver enzymes and glycemic control indices did not changed significantly after soy milk period compared to the cow’s milk period. Among over weight and obese patients, soy milk can play an important role in reducing waist circumference. However, soy milk replacement had no significant effects on weight, glycemic control indices, liver enzymes, fibrinogen and blood pressure in a short term trial.

Soymilk replacement in the diet might have beneficial effects on inflammation and cardiovascular risk factors for non-menopausal overweight and obese female adults. We evaluated the effects of soymilk compared to cow's milk on inflammation and cardiovascular risk factors among overweight and obese female adults.

This was a cross-over randomized clinical trial on 24 subjects. All of them were on a weight reducing diet. There were two trial periods for four weeks (soymilk period and cow's milk period) and a washout period for 2 weeks. In the soymilk period, only one glass of cow's milk (240 cc) was replaced with one glass of soymilk (240 cc).

Mean values of low density lipoprotein (LDL) and waist circumference reduced significantly following soymilk period compared to cow's milk period (LDL: -11.22 ± 3.85 vs. -1.18 ± 2.82; P = 0.01 and waist circumference: -3.79 ± 0.51 vs. -1.78 ± 0.55; P = 0.02). However, inflammatory markers, liver enzymes, blood pressure, other lipid profiles, and glycemic control index did not change significantly after soymilk period compared to cow's milk period.

A diet including soymilk can play an important role in reducing lipid profiles and waist circumference among non-menopausal overweight and obese female adults even in a short time trial. However, diet with soymilk had no significant effects on glycemic index, plasma inflammatory markers, liver enzymes, or fibrinogen level compared to cow's milk in a short term trial.

Few studies have evaluated the effects of soy milk replacement in the diet on inflammatory markers among non-menopausal overweight and obese female adults. We evaluated the effects of soy milk compared to cow's milk on inflammation and lipid profiles among non-menopausal overweight and obese female adults. This cross-over randomized clinical trial was conducted on 24 overweight or obese women. There were two 4-week trial periods (soy milk period and cow's milk period). In the soy milk period, only one glass of soy milk (240 cc) was replaced instead of one glass of cow's milk (240 cc). Fat contents in soy milk and cow's milk were 1 g per 100 ml and 1.5 g per 100 ml, respectively. Serum low density lipoprotein (LDL) level reduced significantly following soy milk period (mean percent change in soy milk period vs. cow's milk period: -11.22 ± 3.85% vs. -1.18 ± 2.82%; p = 0.01). Inflammatory factors and other lipid profiles did not change significantly after the soy milk period compared to the cow's milk period. In addition, soy milk could not reduce the weight of non-menopausal overweight and obese female adults. Soy milk replacement had beneficial effects on LDL levels in a short term trial among overweight and obese women. However, it had no significant effects on inflammatory markers and other lipid profiles among these non-menopausal overweight and obese adults.